MYSTERIOUS: 21 - You Need To See This

WHO Releases Global Guidelines on Using Weight Loss Jabs In Treating Obesity, Warns About Supply Shortage

The World Health Organisation says GLP‑1 weight‑loss jabs, originally for diabetes, can also treat obesity.

International Business Times UK · Dec 2, 2025

Obesity speeds up the development of Alzheimer’s disease, study reveals

Obesity is associated with an increase in dementia risk and researchers can now see that it speeds up the development of Alzheimer’s in particular

The Independent UK · Dec 2, 2025

Warning over weight loss jab shortage as obesity set to double by 2030

GLP-1 medication, such as Wegovy, was added to the list of ‘essential’ medicines by the World Health Organization in September

The Independent UK · Dec 1, 2025

What having a beer belly really says about your health

Excess weight, especially around the waist, leads to fatty material building up in the arteries and major organs

The Independent UK · Dec 1, 2025

Smartphones at age 12 linked to worse health

Preteens who own smartphones are likelier to have depression, obesity and insufficient sleep than their peers.

Axios · Dec 1, 2025

Weight-loss drug doesn’t reduce risk of Alzheimer’s – new studies

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer’s, according to two large new studies. The results close the door, for now, on hopes that a treatment for diabetes and obesity might also help protect the brain.

The Conversation · Nov 28, 2025

We created health guidelines for fighting loneliness - here’s what we recommend

Social isolation kills. It increases your risk of death by 30% — roughly the same as smoking cigarettes and much worse than factors such as obesity and sedentary living.

The Conversation · Nov 24, 2025

Has America's obesity rate plateaued?

Some recent national numbers suggest the obesity rate has plateaued or even declined. Experts are skeptical.

LiveScience · Nov 24, 2025

3 Weight-Loss Drug Stocks To Consider For 2026

The global weight loss drug market, perhaps ironically, is growing like gangbusters these days. Globally, it’s set to expand from $15 billion in 2024 to $150 billion by 2035, according to Morgan Stanley.

Benzinga · Nov 21, 2025

Making GLP-1 weight loss drugs cheaper isn’t enough to address America’s obesity problem – here’s why

The Trump administration is making a significant effort to reduce the cost of weight loss drugs. Its agreement with pharmaceutical giants, announced Nov. 6, 2025, will reduce the monthly prices of these medications by hundreds of dollars.

The Conversation · Nov 21, 2025